Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

08:00 ET VLP Therapeutics Appoints Jacob Licht as Chief Operating Officer

VLP Therapeutics, LLC ("VLP"), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines and...


08:00 ET Marapharm Ventures Inc. 'Marapharm' Announces Progress in California

Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) ("Marapharm" or the "Company") (http://www.marapharm.com/) owns, without debt,...


08:00 ET Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%

Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the...


07:50 ET EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

Not intended for UK-based media - If approved, avelumab could be the first immunotherapy treatment indicated for this rare and...


07:30 ET Regeneron and Sanofi Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicine Agency's (EMA) Committee for Medicinal...


07:30 ET Vascular Access Devices Market Worth 5.45 Billion USD by 2022

According to a new market research report "Vascular Access Device Market by Type [Peripheral (Midline, Short), Central (PICC, Tunneled,...


07:27 ET Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo® (Telotristat Ethyl)

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that the Committee for Medicinal Products for Human Use (CHMP), the committee of the...


07:00 ET Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of Schizophrenia

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today that the European Medicines Agency's Committee for Medicinal Product for Human...


06:30 ET Medical Equipment Stock Performance Review -- Amedica, Neovasc, Accuray, and NuVasive

If you want a Stock Review on AMDA, NVCN, ARAY, or NUVA then come over to http://dailystocktracker.com/register/ and sign up for your free...


06:10 ET Breakfast Technical Briefing on Biotech Stocks -- Aurinia Pharma, Esperion Therapeutics, Paratek Pharma, and Verastem

If you want a Stock Review on AUPH, ESPR, PRTK, or VSTM then come over to http://dailystocktracker.com/register/ and sign up for your free...


05:37 ET New PhRMA resources chock full of biopharma industry facts

Did you know that PhRMA member companies invested $65.5 billion in research and development (R&D) in 2016? Or that combined spending on brand...


03:21 ET Pharma IQ: 16e sommet annuel de l'informatique de laboratoire

Le forum le plus complet sur l'informatique de laboratoire Laboratory Informatics, qui se déroule du 19 au 21 septembre à Amsterdam, est le forum...


01:00 ET Pharming Announces Completion of its Refinancing With a Single US$100 Million Debt Facility on Improved Commercial Terms

Repayment of bridge finance on unchanged terms Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces that it...


01:00 ET Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...


00:00 ET SillaJen and Lee's Pharmaceutical Announce Approval by the China CFDA to Commence Phase 3 Clinical Trial for Oncolytic Immunotherapy, Pexa-Vec, in Liver Cancer

SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for...


Jul 20, 2017, 21:30 ET Erectile Dysfunction Pipeline Drugs and Therapeutics Market H2 2017 Available at RnR Market Research

Erectile Dysfunction Pipeline Drugs and Therapeutics Market H2 2017 report provides latest therapeutics and drugs development for Erectile...


Jul 20, 2017, 20:48 ET PharmMD Launches Industry-Changing Platform That Predicts Star Measure Outcomes

PharmMD announced today a new interactive dashboard for Health Plans looking to maximize resources for Part C/HEDIS and Part D measure success in...


Jul 20, 2017, 19:38 ET Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting from Dompé Research for the Treatment of Moderate to Severe Neurotrophic Keratitis is Made in Italy

- Behind the development of cenegermin are decades of Italian research, stemming from the studies of Rita Levi Montalcini, winner of...


Jul 20, 2017, 18:45 ET Global Alzheimer's Drugs Market to Grow at a CAGR of 1.9% by 2021 - Includes Market Assessment of FDA-approved Drugs

The "Global Alzheimer's Drugs Market 2017-2021" report has been added to Research and Markets' offering. The global alzheimer's drugs market to...


Jul 20, 2017, 17:30 ET Prime Therapeutics Urges Caution on Mandates of Abuse-Deterrent Formulations of Opioids Citing Value Concerns

Prime Therapeutics LLC (Prime) released this statement from its Chief Medical Officer, Jonathan Gavras, M.D., following today's Institute for...


Jul 20, 2017, 16:38 ET FDA Accepts Biologics License Application for AMG 334 (Erenumab), an Important Regulatory Milestone for Novartis

Novartis today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for AMG 334...


Jul 20, 2017, 16:30 ET NERLYNX™ (neratinib) tablets for HER2+ Breast Cancer in the Extended Adjuvant Setting

Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today it has been selected to be in the limited distribution network for Puma Biotechnology, Inc.'s...


Jul 20, 2017, 16:30 ET FDA Accepts Biologics License Application For Aimovig™ (erenumab)

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application...


Jul 20, 2017, 16:15 ET IRIDEX to Report Second Quarter 2017 Financial Results on August 3, 2017

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter 2017 after the close of trading...


Jul 20, 2017, 16:10 ET North America Neurostimulation Devices Market Outlook to 2023

North America Neurostimulation Devices Market Outlook to 2023 Summary GlobalData's new report, "North America Neurostimulation Devices Market...